X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5739) 5739
Publication (407) 407
Newsletter (379) 379
Book Review (96) 96
Newspaper Article (52) 52
Book Chapter (47) 47
Magazine Article (44) 44
Book / eBook (13) 13
Conference Proceeding (9) 9
Dissertation (5) 5
Trade Publication Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cachexia (3778) 3778
humans (3765) 3765
index medicus (2318) 2318
male (2019) 2019
cancer (1689) 1689
female (1654) 1654
cachexia - etiology (1484) 1484
animals (1333) 1333
oncology (1209) 1209
middle aged (1190) 1190
aged (1143) 1143
cancer cachexia (903) 903
neoplasms - complications (882) 882
cachexia - drug therapy (829) 829
adult (808) 808
weight-loss (687) 687
research (684) 684
care and treatment (675) 675
cachexia - therapy (650) 650
mice (636) 636
anorexia (595) 595
nutrition & dietetics (595) 595
quality of life (585) 585
chemotherapy (580) 580
weight loss (573) 573
inflammation (554) 554
skeletal-muscle (543) 543
cachexia - metabolism (513) 513
health aspects (513) 513
sarcopenia (499) 499
nutrition (494) 494
prognosis (486) 486
metabolism (483) 483
medicine, general & internal (466) 466
cytokines (462) 462
cachexia - physiopathology (442) 442
survival (429) 429
analysis (427) 427
body mass index (423) 423
body weight (423) 423
malnutrition (411) 411
rats (408) 408
aged, 80 and over (399) 399
physiological aspects (390) 390
body composition (389) 389
mortality (384) 384
muscles (377) 377
medicine & public health (375) 375
therapy (372) 372
nutritional status (367) 367
quality-of-life (345) 345
heart failure (338) 338
musculoskeletal system (338) 338
tumor-necrosis-factor (336) 336
treatment outcome (326) 326
drug therapy (322) 322
muscle, skeletal - metabolism (319) 319
proteins (312) 312
risk factors (312) 312
anorexia - etiology (310) 310
double-blind (306) 306
obesity (303) 303
body-composition (295) 295
cachexia - complications (295) 295
neoplasms - therapy (293) 293
exercise (286) 286
patients (286) 286
cancer patients (283) 283
surgery (280) 280
cardiac & cardiovascular systems (267) 267
cell biology (267) 267
palliative care (263) 263
skeletal muscle (260) 260
endocrinology & metabolism (257) 257
cachexia - prevention & control (254) 254
cancer therapies (254) 254
muscle, skeletal - pathology (249) 249
neoplasms - metabolism (249) 249
health care sciences & services (248) 248
pharmacology & pharmacy (248) 248
oncology, experimental (246) 246
expression (244) 244
disease (243) 243
medicine (243) 243
geriatrics & gerontology (238) 238
ghrelin (237) 237
megestrol-acetate (236) 236
tumors (234) 234
neoplasms - drug therapy (232) 232
disease models, animal (229) 229
internal medicine (229) 229
dietary supplements (227) 227
article (224) 224
medical research (223) 223
studies (217) 217
prospective studies (214) 214
cachexia - pathology (213) 213
physiology (213) 213
clinical trials (212) 212
appetite (208) 208
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5860) 5860
German (122) 122
French (58) 58
Spanish (51) 51
Japanese (40) 40
Russian (34) 34
Polish (25) 25
Italian (14) 14
Portuguese (10) 10
Chinese (8) 8
Czech (6) 6
Danish (5) 5
Dutch (4) 4
Hungarian (4) 4
Korean (4) 4
Hebrew (3) 3
Swedish (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Slovenian (2) 2
Croatian (1) 1
Finnish (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2013, Volume 108, Issue 3, pp. 486 - 492
Journal Article
Current Opinion in Clinical Nutrition and Metabolic Care, ISSN 1363-1950, 09/2014, Volume 17, Issue 5, pp. 471 - 476
Journal Article
Journal Article